Natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke

Acta Neurologica Scandinavica

Volumn 105, Issue 2, 2002, Pages 107-114

  Haapaniemi, E ^a   Tatlisumak, T ^b   Soinne, L ^b   Syrjala M ^b   Kaste, M ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

Cerebral infarction; Coagulation; Natural anticoagulants; Prognosis; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBIN III; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; RECURRENCE; RISK FACTORS; SERINE PROTEINASE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 0036185893     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.1o112.x     Document Type: Article

References (35)

1. Hematologic disorders associated with ischemic stroke
2. Thrombophilia: A new factor emerges from the mists
3. Prothrombotic states in young people with idiopathic stroke
4. Protein S deficiency in middle-aged women with stroke
5. Hypercoagulability in acute stroke: Prognostic significance
6. Hypercoagulability in acute ischemic stroke: Analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method
7. Coagulation-fibrinolysis abnormalities in acute and chronic phase of cerebral thrombosis and embolism
8. Activation of coagulation in acute cardioembolic stroke
9. Markers of hypercoaguble state following acute ischemic stroke
10. Alterations of haemostatic markers in various subtypes and phases of stroke
11. Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes
12. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation
13. Early prognostic factors in stroke. The role of protein C and protein S
14. Free protein S deficiency: A possible association with cerebrovascular occlusion
15. Free protein S deficiency in acute ischemic stroke
16. Hemostatic disturbances in acute ischemic stroke: A study of 86 patients
17. Classification of subtype of acute ischemic stroke
18. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
19. Protein C in acute stroke
20. Aging-associated changes of thrombin generation and protein C activation in human
21. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment
22. Parameters of haemostasis during acute venous thrombosis
23. Nonvalvular atrial fibrillation: Evidence for a prothrombotic state
24. Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: The atherosclerosis risk in communities (ARIC) study
25. Antithrombin III. Associations with age, race, sex and cardiovascular disease risk factors
26. The PLAT study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients
27. Antithrombin III and arterial disease
28. The VITA project: Population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen relationship with physiological variables and establishment of reference ranges
29. Protein C activity in healthy volunteers-influence of age, sex, smoking and oral contraceptives
30. Antithrombin and atherosclerosis in the Rotterdam study
31. Oral contraceptives and gender affect protein S status
32. The influence of low protein S plasma levels in young women on the definition of normal range
33. Influence of demographic factors on antithrombin III activity in a healthy population
34. Haemostatic effects of supraphysiological levels of testosterone in normal men
35. Predisposing factors of recurrent embolization in cardiogenic cerebral embolism